Skip to content

Total Equity at other companies

Eli Lilly logo
Eli LillyLLY
$31.2B+97.9%
AbbVie logo
AbbVieABBV
-$6.66B-569%
Establishment Labs logo
Establishment LabsESTA
$14.78M-61.7%
Bausch Health Companies logo
Bausch Health CompaniesBHC
-$2.06B-74.0%

Other financials

Income statement

See full
Revenue$39.4M0.0%
Gross profit$23.8M+1.6%
Operating income-$1.8M-13.4%
Net income-$2.4M+15.8%
EPS (diluted)-$0.03+40.0%

Balance sheet

See full
Cash & equivalents$16.7M+201%
Total debt$71.0M-27.1%
Total assets$192.0M-5.5%

Cash flow

See full
Operating cash flow$5.3M+507%
CapEx$51.0K-97.3%
Free cash flow$5.2M+605%

Valuation

See full
Market cap$311.81M+4.7%
Enterprise value$366.14M-6.0%
P/S2.1×+0.3×

Profitability

See full
Gross margin59.6%-0.3pp
Operating margin-7.8%-0.4pp
Net margin-11.3%-25.1pp
FCF margin-0.1%

Returns & leverage

See full
Return on equity-21.6%-78.3pp
Debt / equity0.7×-0.6×
Current ratio0.7×+0.2×

Where this comes from

Reported directly by AirSculpt Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: AirSculpt Technologies, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AirSculpt Technologies, Inc.'s total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AirSculpt Technologies, Inc.'s total equity?
AirSculpt Technologies, Inc. (AIRS) reported total equity of $100.26M in Q1 2026.
How has AirSculpt Technologies, Inc.'s total equity changed year-over-year?
AirSculpt Technologies, Inc.'s total equity increased by 31.5% year-over-year, from $76.23M to $100.26M.
What is the long-term trend for AirSculpt Technologies, Inc.'s total equity?
Over 4 years (2021 to 2025), AirSculpt Technologies, Inc.'s total equity has grown at a 1.2% compound annual growth rate (CAGR), from $83.53M to $87.71M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.